37 related articles for article (PubMed ID: 21302907)
1. Triptolide abrogates oncogene FIP1L1-PDGFRalpha addiction and induces apoptosis in hypereosinophilic syndrome.
Jin Y; Chen Q; Lu Z; Chen B; Pan J
Cancer Sci; 2009 Nov; 100(11):2210-7. PubMed ID: 19671059
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic leukemia; case report.
GLOETZNER HJ; MARX HE
Del State Med J; 1947 Jan; 19(1):12-4. PubMed ID: 20281837
[No Abstract] [Full Text] [Related]
3. Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.
Prieto-Bermejo R; Romo-González M; Pérez-Fernández A; Ijurko C; Hernández-Hernández Á
J Exp Clin Cancer Res; 2018 Jun; 37(1):125. PubMed ID: 29940987
[TBL] [Abstract][Full Text] [Related]
4. An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.
Dutoit-Lefèvre V; Dubucquoi S; Launay D; Sobanski V; Dussart P; Chafey P; Broussard C; Duban-Deweer S; Vermersch P; Prin L; Lefranc D
PLoS One; 2015; 10(7):e0132142. PubMed ID: 26132557
[TBL] [Abstract][Full Text] [Related]
5. Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting.
Fernandez-Gomez FJ; Jumeau F; Derisbourg M; Burnouf S; Tran H; Eddarkaoui S; Obriot H; Dutoit-Lefevre V; Deramecourt V; Mitchell V; Lefranc D; Hamdane M; Blum D; Buée L; Buée-Scherrer V; Sergeant N
J Vis Exp; 2014 Apr; (86):. PubMed ID: 24747743
[TBL] [Abstract][Full Text] [Related]
6. Endobiogeny: a global approach to systems biology (part 2 of 2).
Lapraz JC; Hedayat KM; Pauly P
Glob Adv Health Med; 2013 Mar; 2(2):32-44. PubMed ID: 24416662
[TBL] [Abstract][Full Text] [Related]
7. ICON: Eosinophil Disorders.
Valent P; Klion AD; Rosenwasser LJ; Arock M; Bochner BS; Butterfield JH; Gotlib J; Haferlach T; Hellmann A; Horny HP; Leiferman KM; Metzgeroth G; Matsumoto K; Reiter A; Roufosse F; Rothenberg ME; Simon HU; Sotlar K; Vandenberghe P; Weller PF; Gleich GJ
World Allergy Organ J; 2012 Dec; 5(12):174-81. PubMed ID: 23282419
[No Abstract] [Full Text] [Related]
8. Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL.
Li B; Zhang G; Li C; He D; Li X; Zhang C; Tang F; Deng X; Lu J; Tang Y; Li R; Chen Z; Duan C
PLoS One; 2012; 7(4):e34912. PubMed ID: 22523564
[TBL] [Abstract][Full Text] [Related]
9. FIP1L1/PDGFR alpha-associated systemic mastocytosis.
Yamada Y; Cancelas JA
Int Arch Allergy Immunol; 2010; 152 Suppl 1(Suppl 1):101-5. PubMed ID: 20523072
[TBL] [Abstract][Full Text] [Related]
10. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.
Gotlib J; Akin C
Semin Hematol; 2012 Apr; 49(2):128-37. PubMed ID: 22449623
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic analysis of blood eosinophils reveals redox signaling modifications in patients with FIP1L1-PDGFRA-associated chronic eosinophilic leukemia.
Kahn JE; Dutoit-Lefevre V; Duban-Deweer S; Chafey P; Pottiez G; Lefranc D; Fain O; Cordier JF; Hatron PY; Bletry O; Prin L
J Proteome Res; 2011 Apr; 10(4):1468-80. PubMed ID: 21302907
[TBL] [Abstract][Full Text] [Related]
12. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M is a FIP1L1/PDGFRA-dependent mediator of cytokine production in chronic eosinophilic leukemia.
Hoermann G; Cerny-Reiterer S; Sadovnik I; Müllauer L; Bilban M; Gröger M; Horny HP; Reiter A; Schmitt-Graeff A; Mannhalter C; Valent P; Mayerhofer M
Allergy; 2013 Jun; 68(6):713-23. PubMed ID: 23621172
[TBL] [Abstract][Full Text] [Related]
14. Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA.
Sadovnik I; Lierman E; Peter B; Herrmann H; Suppan V; Stefanzl G; Haas O; Lion T; Pickl W; Cools J; Vandenberghe P; Valent P
Exp Hematol; 2014 Apr; 42(4):282-293.e4. PubMed ID: 24407160
[TBL] [Abstract][Full Text] [Related]
15. [The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib].
Li B; Zhang GS; Dai CW; Pei MF
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):448-52. PubMed ID: 15854548
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
